Online learning (free) to learn about the cell therapy process, including CAR-T, and manufacturing methods under GMP.
This course is divided into upstream, scale-up, and downstream applications, providing a series of technical knowledge. You will learn the steps of a typical workflow in cell therapy manufacturing, covering topics such as cell separation, expansion, harvest, and cryopreservation. Through this course, you will learn how automation and closed-system processes can contribute to the manufacturing of reproducible therapies. Guidance on creating, documenting, automating, and digitizing standard operating procedures (SOPs) will also be provided.
Inquire About This Product
basic information
Since it is an online course, you can take it whenever you like.
Price information
It is a free course.
Price range
P1
Delivery Time
P1
Applications/Examples of results
This is an online course where you can learn about GMP manufacturing of cell therapies, including CAR-T.
Company information
Cytiva and Pall Life Sciences have merged their businesses and will officially launch under the "Cytiva" brand on May 1, 2023. Under our mission of "Advancing therapies, faster," we will integrate both organizations and focus even more on supporting the development and manufacturing of better therapies for patients as a stronger global provider of technologies and services. The new Cytiva will offer a broader and deeper expertise and a rich lineup of products and services to better support various customers involved in research and the manufacturing and development of biopharmaceuticals, enabling them to deliver therapies to patients more quickly, from discovery to delivery. With a rich history spanning several hundred years, Pall Life Sciences and Cytiva, as part of the Danaher Group, will continue to unite to provide better services to our customers.